PhaseBio
Susan has led all preclinical and assay development activities at PhaseBio since its relocation to Malvern, PA. Prior to PhaseBio, Susan was a Preclinical Project Manager at NuPathe Inc. Earlier in her career, she held positions of increasing responsibility at Viromed Biosafety Laboratories, Targeted Genetics, and BioRexis Pharmaceutical. Susan received a BA in biology from Holy Family University and an MS in cell biology and biotechnology and a Ph.D. in cell and molecular biology from the University of the Sciences in Philadelphia.
This person is not in any offices
PhaseBio
PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases.